Reddit Posts
Achieve Life Sciences [ACHV]: Upcoming Nicotine Cessation Drug
Achieve Life Sciences [ACHV]: Upcoming Nicotine Cessation Drug
Why $GUTS and $ACHV Are My Top Biotech Picks for 2026
Top 5 Under Six Dollar Biotech Setups With Real Catalysts On Deck
Top 5 Under Six Dollar Biotechs With Clear Catalysts And Defined Failure Points
Top 3 Small Cap Biotech Setups With Real Near Term Movement Potential
Achieve Life Sciences, Inc. Common Shares (ACHV) Earnings Report Date Nov. 6
Why I think $ACHV has all the right ingredients needed to give a 10x return or more
ACHV ceo right now in London getting the news
$ACHV just got the national priority review voucher NPV
All the A’s-which one to go for this week?
[DD] Achieve Life Sciences (ACHV) – Upcoming FDA Milestone with Cytisinicline
Should we be wary of ACHV?
$ACHV Follow-up DD: Breakout is starting
Look out for this stock: ACHV, with near term catalyst
ACHV — FDA NDA Acceptance to be expected Monday (99.9% odds)
ACHV — FDA NDA Acceptance to be expected Monday (99.9% odds)
$ACHV potential squeeze. Low float
Achieve Life Sciences (ACHV): Recent Financials and Outlook
Raymond James says ACHV will surge to $20 (it's at less than $3 now) — big opportunity ahead
Quick Follow-Up: SORA, LHSW, ACHV Moves
Quick Follow-Up: SORA, LHSW, ACHV Moves + Noctiq 2.0 is Live
THIS WEEK ACHV, SORA, and LHSW 10–20% move potential
ACHV - June NDA submission- smoking cessation
large oversold ready to go for the moon
The penny stocks that are buys right now in the biopharmaceutical industry
Mentions
CING, ACHV, RXRX, DRTS/DRTSW a million times, RVPH, CGTX
I'm buying SOFI, RDDT, ACHV currently. I don't buy and hold too many individuals. I hold VOO and sell options mostly.
Anyone tracking ACHV Seems like it has potential with big catalysts coming very soon
anyone playing ACHV? I'm looking to get some calls but lowkey might be way too late of an entry and smarter to buy puts lmaoo
Add in ACHV, SYRE, DRTS
It's a gamble but ACHV. Small biotech pending FDA approval in June for a quit smoking drug. Also it just tanked today because it might get diluted. I'm loading up. It's my only gamble play. Nothing crazy, a few percent of the portfolio and adding extra cash every week.
Mr. President is wrong! $ACHV is the play against smoking AND vaping.
🚨 TABEX IS COMING TO AMERICA AND NICOTINE PATCHES + GUMS ARE ABOUT TO GO STRAIGHT TO THE TRASH 🚨 I quit smoking 10 years ago with this exact Bulgarian molecule. Not patches. Not gums. Not Chantix nightmares. Just a plant-based pill that kills the craving in 6–12 weeks. I’ve been free ever since. Not a single cigarette. Not a single “lifetime subscription” to Big Pharma’s addiction machine. And now $ACHV is about to bring it to the US. PDUFA date: \*\*June 20, 2026\*\* Less than \*\*100 days left\*\*. Who the hell is going to buy nicotine patches and gums after this? I’m asking seriously: how many people do you know who actually quit smoking with that garbage?! There is a perfect symbiosis between Big Tobacco and Big Pharma: one gets you addicted, the other pretends to treat you… with more nicotine. It’s absurd. A pure money-printing machine built on your addiction. Here’s why this could be the craziest play of 2026: 1. The Kazanlak factory is already loaded and ready to fire Sopharma just finished a massive cGMP upgrade. 2,000 tons of raw material → 70 tons of pure cytisine per year. This isn’t a garage lab. This is industrial-scale production built specifically for the US market. They didn’t spend millions on a 70-ton beast for “maybe”. This is a loaded cannon for Day 1. 2. Ognyan Donev is dumping personal millions like crazy The CEO and majority owner of Sopharma is aggressively buying millions of warrants and shares in March 2026. When the guy who controls the factory is betting his own money this hard right now – that’s not “support”. That’s \*\*conviction on steroids\*\*. 3. The data is insane, the market is gigantic \- Over 60 years in Europe – millions of doses sold, it works. \- Phase 3 crushed it. Breakthrough for vaping. Priority Voucher. Clean safety profile. \- Smoking cessation + vaping market = \*\*tens of billions\*\* and exploding fast. If this gets approved, patches and gums will look like cassette players in 2026. https://preview.redd.it/ywd1fj4e5sog1.jpeg?width=750&format=pjpg&auto=webp&s=c366f841d94ae716b037d849d7f74a8987f591f9 4. The setup is pure FOMO hell \- Institutions already own \~47% (Franklin, Propel Bio piling in). \- Short interest \~13% → squeeze fuel ready to ignite. \- Analyst targets $12–$19 (260–350% upside from here). \- No massive hiring for a solo launch → whispers of huge partnership / buyout. \- Quiet period + <100 days = this thing can explode any second. I’m not saying it’s 100%. FDA can say no. But I’ve lived this molecule. I know it works. And right now the entire setup looks like a bomb with a ticking timer. If you’re still holding $MO or $PM because “they pay dividends” – enjoy the slow bleed. The people who get in before June 20 might be laughing out loud in a few months. Not financial advice. Just a guy who quit 10 years ago telling you: don’t sleep on this. $ACHV – the cure Big Tobacco and Big Pharma fear the most. Don’t fade the guy who owns the factory. Who’s still sleeping? ⏰⏰⏰
https://preview.redd.it/ck69r1144sog1.jpeg?width=750&format=pjpg&auto=webp&s=b7f51dda483c38502db2d5cd7b2de9e485e2e587 🚨 TABEX IS COMING TO AMERICA AND NICOTINE PATCHES + GUMS ARE ABOUT TO GO STRAIGHT TO THE TRASH 🚨 I quit smoking 10 years ago with this exact Bulgarian molecule. Not patches. Not gums. Not Chantix nightmares. Just a plant-based pill that kills the craving in 6–12 weeks. I’ve been free ever since. Not a single cigarette. Not a single “lifetime subscription” to Big Pharma’s addiction machine. And now $ACHV is about to bring it to the US. PDUFA date: \*\*June 20, 2026\*\* Less than \*\*100 days left\*\*. Who the hell is going to buy nicotine patches and gums after this? I’m asking seriously: how many people do you know who actually quit smoking with that garbage?! There is a perfect symbiosis between Big Tobacco and Big Pharma: one gets you addicted, the other pretends to treat you… with more nicotine. It’s absurd. A pure money-printing machine built on your addiction. Here’s why this could be the craziest play of 2026: 1. The Kazanlak factory is already loaded and ready to fire Sopharma just finished a massive cGMP upgrade. 2,000 tons of raw material → 70 tons of pure cytisine per year. This isn’t a garage lab. This is industrial-scale production built specifically for the US market. They didn’t spend millions on a 70-ton beast for “maybe”. This is a loaded cannon for Day 1. 2. Ognyan Donev is dumping personal millions like crazy The CEO and majority owner of Sopharma is aggressively buying millions of warrants and shares in March 2026. When the guy who controls the factory is betting his own money this hard right now – that’s not “support”. That’s \*\*conviction on steroids\*\*. 3. The data is insane, the market is gigantic \- Over 60 years in Europe – millions of doses sold, it works. \- Phase 3 crushed it. Breakthrough for vaping. Priority Voucher. Clean safety profile. \- Smoking cessation + vaping market = \*\*tens of billions\*\* and exploding fast. If this gets approved, patches and gums will look like cassette players in 2026. 4. The setup is pure FOMO hell \- Institutions already own \~47% (Franklin, Propel Bio piling in). \- Short interest \~13% → squeeze fuel ready to ignite. \- Analyst targets $12–$19 (260–350% upside from here). \- No massive hiring for a solo launch → whispers of huge partnership / buyout. \- Quiet period + <100 days = this thing can explode any second. I’m not saying it’s 100%. FDA can say no. But I’ve lived this molecule. I know it works. And right now the entire setup looks like a bomb with a ticking timer. If you’re still holding $MO or $PM because “they pay dividends” – enjoy the slow bleed. The people who get in before June 20 might be laughing out loud in a few months. Not financial advice. Just a guy who quit 10 years ago telling you: don’t sleep on this. $ACHV – the cure Big Tobacco and Big Pharma fear the most. Don’t fade the guy who owns the factory. Who’s still sleeping? ⏰⏰⏰
# $ACHV: The Day the Nicotine Monopoly Dies. 🧬🔥 **Look at these photos.** This isn’t a concept. This isn’t a laboratory dream. This is **Tabex** – a real, plant-based medicine that has been crushing nicotine addiction in Europe for **60 years**. If the FDA approves this on June 20th, the multi-billion dollar NRT (Nicotine Replacement Therapy) market **dies the very next day.** Here is why. # 1. The Death of Gums, Patches, and Synthetics Let’s be real: Who is the idiot that tries to beat a nicotine addiction by... feeding it **more** nicotine? Gums and patches are a scam designed to keep you a "customer," not to cure you. And Pfizer’s *Chantix*? A synthetic mess with "Black Box" warnings and nasty side effects. * **The $ACHV Reality:** Once this hits the US market, gums, patches, and Chantix are **OVER**. Why would anyone use useless nicotine-loaded trash when they can have a plant-based molecule that blocks the receptors and kills the urge in 6-12 weeks? **It’s Game Over.** # 2. The Industrial Beast: Sopharma & Kazanlak 🇧🇬 Achieve Life Sciences isn’t just a small office in Seattle. They have the ultimate industrial backbone: **Sopharma**, the Bulgarian pharmaceutical giant. * **The Brand New Factory:** Sopharma just built a state-of-the-art facility in **Kazanlak, Bulgaria**, dedicated to this. * **70-Ton Capacity:** This isn’t "small batch." They have a **70-ton annual capacity** for the active ingredient. They are ready to flood the US and global markets from Day 1. * **The CEO is Buying:** Ognyan Donev (Sopharma’s boss) has been aggressively buying shares and warrants. He knows the factory is ready. He knows the science is flawless. He is betting millions on this "Western Expansion." # 3. 60 Years of Proof vs. FDA Corruption * **Millions Cured:** This drug has saved over 20 million lives in Eastern Europe. It’s sold over-the-counter. It’s safe. It’s effective. * **The Corruption Barrier:** The only reason you don’t have this in your local CVS yet is pure **FDA corruption**. Big Pharma lobbies hard to keep their $13B "addiction subscription" alive. They don’t want a cure; they want a recurring payment. * **Breakthrough Status:** Even the FDA couldn’t deny the data anymore – they granted $ACHV **Breakthrough Therapy Designation** because the results for vaping and smoking were too good to hide. # 4. The Verdict The science is settled. The factory is pumping. The insiders are loading. If this doesn't reach the market, don't blame the science – blame the lobbyists. But if it breaks through, it will be the biggest disruption in pharmaceutical history. I’m holding because I don't bet against a 60-year track record of success. **The era of nicotine-trap products is over. $ACHV is the cure they are afraid of.** https://preview.redd.it/4worpyj0wrog1.jpeg?width=750&format=pjpg&auto=webp&s=9751d9640fb1e9e478aa8e8786695555630f4c8b
Thanks for your info, man, I got smaller positions in DTIL, HELP and ACHV now.
ACHV. It’s going to be mahooosive!
$ACHV - Achieve Life Sciences. This is a small-cap biotech producing cystisinicline to target smoking and vaping cessation. It has a PDFUA for June and the drug has been regularly proven safe and effective through past international use and current studies. Clearer candidates I am also investing into include MSFT and AMZN. I am fading NFLX until this downward pressure lets up, its unforgiving over there.
Would love an invite. No long term trades right now. Been mostly playing short dated SPY contracts. I did a DD on ACHV last summer tho
Lots of ACHV December calls. It's biotech so I wouldn't recommend it. But I'll be buying hood, sofi, bull, eth, maybe rddt Then I'm deep diving into lots of others
ACHV December calls. I rarely buy options but I like this one. Other than that I bought a few ETH. Then selling puts on HOOD and going deep into BULL. Prolly sell some SOFI puts.
Buying tons of ACHV December calls while they're cheap tomorrow. Think we're at the bitcoin low, possibly another 10% but we'll see. Although I like Bitcoin I'm against MSTR. It's too much risk and the upside now is awful with so many other Bitcoin proxies.
Ya just like 2 months ago. I was trying to buy cytisine(quit smoking drug) online again but Amazon was out. I looked online for hours and stumbled upon Achieve Life Sciences (ACHV) and they're going for USA FDA approval by June 2026. It isn't FDA approved in the USA yet and has been used in Europe for a couple decades. I bought some shares and called options. Not many but enough.
ACHV seems to be going on a little run this week
I bought ACHV a few days ago, but not much just 1,000 shares
My only real gamble this year so far is ACHV. Other gambling types are BULL, MARA and GME. Other than those it's just boring stocks.
Biotech, eh? Any thoughts ON ACHV? I have lots of June 2026 calls.
ACHV calls for June. If you mean just for tomorrow then 0dte SPY options. Flip a coin for calls or puts. For the strike just fucking guess. 🤷
Buying more ACHV calls for June 26.
ACHV could maybe 10x or more BULL could maybe 5x
Buying more ACHV calls. Not a yolo at all but I think it has very positive EV. Low liquidity kinda sucks though so I gotta set orders and keep an eye on them because the spreads are so wide.
My gamble play is ACHV calls. June 2026 $7.5 mostly and $10's.
I'm buying a bunch of ACHV calls $7.5 and $10 June26. Shares: BULL, GME A little SOFI, HOOD and BTC proxies if they go down more. I mostly trade options though.
Buying some $10 and $7.5 ACHV June calls
I stumbled upon ACHV. A company trying to get FDA approval for a quit smoking drug. They have the Commissioner’s National Priority Voucher (CNPV), to fast track the approval process. I've been taking it and it works very well to reduce cravings. Much better than anything else I've tried and I've tried it all. It's legal in parts of Europe and I got it from there. It's the same drug but not FDA approved in the USA, hopefully yet. Hopefully it gets approved. I really think it can help people quit. I bought some shares and some longer dated options.
To be more concrete and less cheeky... I'd say "things that worked before, with a new cast, and lower expectations" \- INTC fits here, but has already run, they still sell large amounts of things people pay for, and got overlooked because they weren't selling the new thing. New cast with Lip-Bu working all the angles and getting noticed. \- Going forward, I think UBER fits. They're not a growth darling anymore, but still the #1 company in a couple different fields that aren't going anywhere. The new management isn't new anymore, but feels like they still don't get full credit for how many things they do. It's not cheap, but might see a couple trends converge to help them out. \- SLB (or really any "oil" stock) - I like SLB because they're on the service end, and have everything needed to transfer to geothermal if that ever becomes favored. Any pop in either sector helps them out and they're trying to rebrand. Low expectations, no reason they can't exceed. \- NVO - worked before and still has core assets that will print for a long time, refocusing, new leadership, and the drama has them just too cheap right now... think ASML 6 months ago On the smaller side FUBO - teamed up with Disney, maybe you've heard of them. Low expectations because they have the less cool side of the streaming bundles, but sports are a thing people like ;) Right now priced like they're going to slowly evaporate. If they post even "mid" quarters, they should change multiples and start seeing effects of Disney selling ads and possibly bundles with ESPN/Disney+/etc... any subscriber growth plus any ARPU lift from ads or innovation and they get the share price out of "penny stock" land under $5, they could be in business. ACHV - gets labeled a biotech, but really licenses a known drug and are walking it through approvals to help people stop smoking. That's "worked before" with Chantix and other entries. Less people smoke, and that ship has sailed, but more people vape (new cast) and ACHV will be in line for early approval on that indication. Valued like speculative biotech, but with a $100M value voucher for accelerated approval that they can sell rather than dilute if needed.
Buying more ACHV calls. Hopefully it goes down more and I can really load up. Getting June 26 $7.5 and $10 calls.
Buying some ACHV calls and a few shares. Calls for June26. Yes, V, not R lol
Oh, very interesting. I actually invested in HBIO last week at .88 but I missed the peak and had to sell at .60. However when I invested in ACHV I had a little gain at sell. I do like the idea of investing in more biotech because I certainly see its benefits! Do the runs typically come after an announcement for breakthroughs? Thanks for the tip/website!
My picks: 1. AMZN 2. RDDT 3. META 4. UNH 5. NVO 6. ACHV
You guys actually wanna invest in something real check out ACHV. Not a penny stock but for a reason on a few dollars before it gets big in June/july
Hey doc, thank you for sharing and great to hear from someone that treats these patients. Here are my houghts and my understanding based on discussions with other experts and doctors as well as my background in a relevant field: 1. There is strong evidence that Cytisinicline has a much cleaner agonist profile with much better tolerability. In a nutshell, it has showed fewer nausea and vivid dream side effects compared to Chantix. Also, as I am sure know, there is an adherence issue with Chantix, as well as bad reputation. 2. Totally agree that vaping is still nicotine addiction. Still vaping is not smoking, especially when it comes to dependence patterns. Higher-frequency dosing, different social cues and younger demographics matter here imo. As such, I have a strong view that FDA labelling (and the associated marketing make a difference here. Achieve can target public health grants, youth programs, new reimbursement codes, etc. 3. Generics are cheap yes, but unpromoted. As such, a branded FDA-approved vaping cessation drug can draw marketing support and get market share. I can almost see some parallels with Contrave/Wegovy (not sure if you are familiar with, but worth checking out). where despite alternative for weight loss, they found markets. 4. Your number 3 is actually is very reassuring for me, as indeed it has been used for a long time in Europe, and, as such, we know it is safe. I also believe that U.S. patients would prefer the U.S. legit version. I still have a strong view that this will be a blockbuster. The FDA priority voucher clearly indicate that it has the potential to cover an urgent public-health need. It does not need to replace generics, even a 2% penetration will make this a blockbuster and ACHV a $Bs market-cap stock.
To the person giving DD on ACHV, thank you very much. Up 65% in a few days. Love to see it? Holding it for long term.
Nice 💪💪💪 I know bynd is taking up every thread on here atm but there's next to none on ACHV, weird that people don't seem to want even more free money
ACHV although not a penny stock it’s still going to 🚀🚀🚀
ACHV up 20% today and like 50% since last week a true gem and not a pump and dump
I'm seeing all kinds of stuff out there popping on volume, not being talked about. RANI SONM ACHV ELDN EQ ELBM IBIO
I’ve been in and tracking ACHV for quite sometime and have posted my findings on Reddit, based on my research. I think your numbers are almost “on”. Price movements will continue short due to MMs repositioning. This last “pop” was suppressed, dark pool tape was just as robust as the lit market.
I’ve been in ACHV for a few months. It’s been pretty flat so was excited to see the news last week. There is a new analyst target of $20. I expect it to be flat for a while until the June PDUFA, although with the bright future ahead we could be bought out earlier. I want to be ready so have shares I will hold long, and also have some 2026 options. If you are on stock twits you can find some good DD if you scroll
Achieve Life Sciences, ACHV
$15.50 on Yahoo! Finance: [Achieve Life Sciences, Inc. (ACHV) Stock Price, News, Quote & History - Yahoo Finance](https://finance.yahoo.com/quote/ACHV/)
ACHV got fast tracked approval 1-2 months for its vaping drug
Downvotes are compliments. I mentioned ACHV a few times, including premarket. It's up over 40%. Must be bitter BYND investors, lol.
ACHV...Moving! Nobody else in? Great catalyst today and great volume!
Personally, I bought FEMY, ACHV, and (one share of) INTS. Considering getting back into GWH after a loss and trying to find the right time in on RR - although neither of those are in "penny" range anymore, technically. Also eyeing ELBM.
ACHV: Holding strong after market open profit taking. Great catalyst today. Good volume. Looks like support right now is about 3.82
ACHV: Nice move on really good catalyst and good volume.
ACHV Up 20%+ pre market, just got accepted for FDA priority reducing process from a year to 1-2 months. Providing a nicotine cessation solution that is used globally into a market that has been deprived a solution for decades. Market cap is only ~200M - The Global Cytisine Market, estimated at 7.59 billion in 2025, is anticipated to grow at a CAGR of 15.02% from 2026 to 2033, reaching 17.57 billion by 2033. The market’s expansion is driven by increasing demand, rapid technological advancements, and the growing adoption of solutions across diverse industry sectors. A manufacturing patent in the largest global market could be 10-100x opportunity
ACHV: Good movement and volume. Great catalyst today. 7 analysis = 100% buy
ACHV: Volume already at daily average. Great catalyst news today as it received national priority voucher for treatment of nicotine dependency Could be a great play in tough market today.
ACHV: Good catalyst... Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation https://www.stocktitan.net/news/ACHV/achieve-life-sciences-receives-fda-commissioner-s-national-priority-z9ensthvij0v.html
ACHV playing with my emotions
ACHV playing with my emotions haha
ACHV and RVPH. Give it a year and these stocks will 5x
Anyone think ACHV is a good buy?
ACHV, SCWO and RVPH all will x5 over the next year
Anyone here long in ACHV. Pretty stable price for a biotech and has a proven product cytisinicline
ACHV and CTM. Pretty stable prices and good financials
ACHV, if u can wait till next year may-jun.
Some retard on here talked me into buying ACHV and now im bagholding whatever the fuck this is. Hopefully this pays off, just plan on holding it long term
You're holding too long. There are some biotechs that are longer holds, like ACHV; ADAP and PRPH are not among these.
Def looking at ACHV (PDUFA next year) SPRO (PDUFA next year with partner), GOSS (Data in Feb2026) and INO (Maybe approval mid 2026) along with QNCX (Data 1st Q 2026)
Fubo, WBD, and PSKY are good ones to be holding as well. Fubo is about to make jump. Bayer, ACHV, and MBOT are also good BUY contenders that I do have positions of. The charts look good for them.
Come onnnnn ACHV keep going so I feel like less of an ass for buying in late
ACHV , FUBO, RZLV, and AIRE popped today. Very nice to see 👌 Anyone take profits today?
ACHV. Potantial sleeping giant. FDA approved it to inspect. Phases are success. Very low marketcap for very big market.
What do you guys think of ACHV? I bought about $1000 worth of shares at 2.76 and will try to pick up some December 2026 calls, liquidity so low tho
ATYR, ACHV, CLRB, -- gamble NWBO
I bought some shit stock ACHV after reading some retarded dd on here. Can you guys pump it so I can exit? Thank you for your attention to this matter
ACHV it’ll be dead money for 9 months so tuck it away.
Don't ask these ACHV shills what the stock is going to do. Over the last two weeks they all posted to state it was going to $5 on this acceptance news.
why isn’t ACHV flying like everyone said it would?
buying ACHV dip, FDA accepted the new drug
ACHV just got their NDA accepted
Boom... With the UFDA September 3, 2025 8:31 AM Achieve Life Sciences Inc. (NASDAQ: ACHV) announced the U.S. Food and Drug Administration has accepted its new drug application for cytisinicline, a treatment for nicotine dependence and smoking cessation in adults. The FDA set a Prescription Drug User Fee Act target action date of June 20, 2026.